These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31478977)

  • 1. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
    Mao R; Li K; Cai JQ; Luo S; Turner M; Blazer D; Zhao H
    Ann Surg; 2021 Aug; 274(2):e126-e133. PubMed ID: 31478977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma.
    Schmitz R; Mao R; Moris D; Strickler JH; Blazer DG
    Ann Surg Oncol; 2021 Jan; 28(1):114-120. PubMed ID: 32556871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Seisen T; Krasnow RE; Bellmunt J; Rouprêt M; Leow JJ; Lipsitz SR; Vetterlein MW; Preston MA; Hanna N; Kibel AS; Sun M; Choueiri TK; Trinh QD; Chang SL
    J Clin Oncol; 2017 Mar; 35(8):852-860. PubMed ID: 28045620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of association between center colorectal neuroendocrine neoplasm volume and survival among patients with colorectal neuroendocrine carcinoma.
    Suraju MO; Freischlag K; McKeen A; Nayyar A; Thompson D; Gordon DM; Mishra A; Sherman SK; Goffredo P; Hassan I
    J Surg Oncol; 2024 Jun; 129(8):1449-1455. PubMed ID: 38685721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
    Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
    Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
    Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
    JAMA Netw Open; 2024 Jan; 7(1):e2351502. PubMed ID: 38206623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer.
    Guo Q; Lan T; Lu Y; Hu Z; Xu H; Wang X; Shao X; Fu X
    Biomol Biomed; 2023 May; 23(3):502-509. PubMed ID: 36408954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
    Fields AC; Lu P; Vierra BM; Hu F; Irani J; Bleday R; Goldberg JE; Nash GM; Melnitchouk N
    Ann Surg Oncol; 2019 Apr; 26(4):1127-1133. PubMed ID: 30706232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases.
    Chen Q; Li K; Rhodin KE; Masoud SJ; Lidsky ME; Cai J; Wei Q; Luo S; Zhao H
    J Surg Oncol; 2023 May; 127(6):945-955. PubMed ID: 36807890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
    Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
    J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    Wakeam E; Adibfar A; Stokes S; Leighl NB; Giuliani ME; Varghese TK; Darling GE
    J Thorac Cardiovasc Surg; 2020 May; 159(5):2043-2054.e9. PubMed ID: 31759623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
    Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
    Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
    Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
    Lin JP; Zhao YJ; He QL; Hao HK; Tian YT; Zou BB; Jiang LX; Lin W; Zhou YB; Li Z; Xu YC; Zhao G; Xue FQ; Li SL; Fu WH; Li YX; Zhou XJ; Li Y; Zhu ZG; Chen JP; Xu ZK; Cai LH; Li E; Li HL; Xie JW; Huang CM; Li P; Lin JX; Zheng CH
    Br J Surg; 2020 Aug; 107(9):1163-1170. PubMed ID: 32323879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of chemotherapy for patients with pT3N0M0 renal pelvic urothelial carcinomas: An inverse probability of treatment weighting comparison using Surveillance, Epidemiology, and End Results data.
    Liu Z; Huang J; Li X; Huang C; Ye Y; Zhang J; Liu Z
    Cancer Med; 2020 Aug; 9(16):5756-5766. PubMed ID: 32585775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection.
    Polanco PM; Mokdad AA; Zhu H; Choti MA; Huerta S
    JAMA Oncol; 2018 Jul; 4(7):938-943. PubMed ID: 29710272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours.
    Pellat A; Walter T; Augustin J; Hautefeuille V; Hentic O; Do Cao C; Lievre A; Coriat R; Hammel P; Dubreuil O; Cohen R; Couvelard A; André T; Svrcek M; Baudin E; Afchain P
    Neuroendocrinology; 2020; 110(5):404-412. PubMed ID: 31430756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.